Literature DB >> 26588919

Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP).

Rosanna Tortelli1, Massimiliano Copetti2, Simona Arcuti1, Marianna Tursi3, Annalisa Iurillo3, Maria Rosaria Barulli1, Rosa Cortese3, Rosa Capozzo1, Eustachio D'Errico3, Benoit Marin4,5,6, Isabella Laura Simone3, Giancarlo Logroscino7,8.   

Abstract

The aim of this study is to investigate the frequency and the clinical correlations of pseudobulbar affect (PBA) in a population-based incident cohort of ALS patients. Incident ALS cases, diagnosed in 2011 and 2012, according to El Escorial criteria were enrolled from a prospective population-based registry in Apulia, Southern Italy. Neurological status was assessed using a standard neurological examination and the revised ALS Functional Rating Scale (ALSFRSr). The Center for Neurologic Study-Lability Scale (CNS-LS), a self-administered questionnaire, was used to evaluate the presence and severity of PBA. Total scores range from 7 to 35. A score ≥13 was used to identify the presence of PBA. One-hundred thirty-two sporadic incident ALS cases were enrolled. Median disease duration was 20 months (range 2-143), median onset-diagnosis interval (ODI) 12 months (range 2-131), median ALSFRSr at baseline 36/48 (range 2-47) and median ALSFRSr bulbar sub-score 10/12 (range 0-12). Neurological examination revealed presence of PBA in 34/132 patients (26%). Pathological CNS-LS score was found in 45/132 patients (34%). Median total CNS-LS score was 9/35 (range 7-29). The subgroup with pathological CNS-LS was characterized by a short disease duration from symptom onset, ODI, time to diffusion to a second region, time to generalization and ALSFRSr bulbar sub-score, bulbar onset, "definite" diagnostic category, bulbar upper motor-neuron involvement and presence of PBA at neurological examination. In population-based setting, one-third of ALS patients present PBA at diagnosis. The presence of PBA is associated with bulbar UMN involvement and markers of a more severe phenotype.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Pseudobulbar affect

Mesh:

Year:  2015        PMID: 26588919     DOI: 10.1007/s00415-015-7981-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction.

Authors:  S McCullagh; M Moore; M Gawel; A Feinstein
Journal:  J Neurol Sci       Date:  1999-10-31       Impact factor: 3.181

2.  Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers.

Authors:  Kerri A Schoedel; Laura E Pope; Edward M Sellers
Journal:  Clin Drug Investig       Date:  2012-03-01       Impact factor: 2.859

3.  Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy.

Authors:  Anna Montuschi; Barbara Iazzolino; Andrea Calvo; Cristina Moglia; Leonardo Lopiano; Gabriella Restagno; Maura Brunetti; Irene Ossola; Anna Lo Presti; Stefania Cammarosano; Antonio Canosa; Adriano Chiò
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-04-25       Impact factor: 10.154

4.  The seeds of neurodegeneration: prion-like spreading in ALS.

Authors:  Magdalini Polymenidou; Don W Cleveland
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

Review 5.  Pathological laughing and crying.

Authors:  F L Dark; J J McGrath; M A Ron
Journal:  Aust N Z J Psychiatry       Date:  1996-08       Impact factor: 5.744

6.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

Review 7.  Neuroanatomy of pathological laughing and crying: a report of the American Neuropsychiatric Association Committee on Research.

Authors:  Josef Parvizi; Kerry L Coburn; Samuel D Shillcutt; C Edward Coffey; Edward C Lauterbach; Mario F Mendez
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

Review 8.  Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues.

Authors:  G Logroscino; B J Traynor; O Hardiman; A Chio'; P Couratier; J D Mitchell; R J Swingler; E Beghi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-01       Impact factor: 10.154

Review 9.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

10.  PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions.

Authors:  Benjamin Rix Brooks; David Crumpacker; Jonathan Fellus; Daniel Kantor; Randall E Kaye
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

View more
  4 in total

1.  Brainstem Correlates of Pathological Laughter and Crying Frequency in ALS.

Authors:  Sicong Tu; Mengjie Huang; Jashelle Caga; Colin J Mahoney; Matthew C Kiernan
Journal:  Front Neurol       Date:  2021-07-08       Impact factor: 4.003

2.  Laughter, crying and sadness in ALS.

Authors:  Nimish J Thakore; Erik P Pioro
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-06-01       Impact factor: 10.154

Review 3.  Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives.

Authors:  Osama A Khairoalsindi; Ahmad R Abuzinadah
Journal:  Neurol Res Int       Date:  2018-08-12

4.  Alleviation of Psychological Distress and the Improvement of Quality of Life in Patients With Amyotrophic Lateral Sclerosis: Adaptation of a Short-Term Psychotherapeutic Intervention.

Authors:  Moritz Caspar Franz Oberstadt; Peter Esser; Joseph Classen; Anja Mehnert
Journal:  Front Neurol       Date:  2018-04-16       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.